.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Cipla
Citi
Covington
Chinese Patent Office
Johnson and Johnson
Julphar
Baxter
Fish and Richardson
Argus Health

Generated: June 23, 2017

DrugPatentWatch Database Preview

TERBINAFINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Terbinafine Hydrochloride, and when can generic versions of Terbinafine Hydrochloride launch?

Terbinafine Hydrochloride is a drug marketed by Taro, Breckenridge Pharm, Harris Pharm, Roxane, Wockhardt, Invagen Pharms, Mylan, Cipla Ltd, Glenmark Generics, Orchid Hlthcare, Gedeon Richter Usa, Teva, Dr Reddys Labs Inc, Aurobindo Pharma, and Apotex. and is included in sixteen NDAs.

The generic ingredient in TERBINAFINE HYDROCHLORIDE is terbinafine hydrochloride. There are twenty-five drug master file entries for this compound. Fifty-four suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the terbinafine hydrochloride profile page.

Summary for Tradename: TERBINAFINE HYDROCHLORIDE

Patents:0
Applicants:15
NDAs:16
Suppliers / Packagers: see list51
Bulk Api Vendors: see list66
Clinical Trials: see list2,263
Patent Applications: see list763
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TERBINAFINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: TERBINAFINE HYDROCHLORIDE

Ingredient-typeAllylamine
Drug ClassAllylamine Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
CREAM;TOPICAL077511-001Jul 2, 2007OTCNoNo► Subscribe► Subscribe
Mylan
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077136-001Jul 2, 2007DISCNNoNo► Subscribe► Subscribe
Roxane
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077223-001Jul 2, 2007DISCNNoNo► Subscribe► Subscribe
Teva
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL076377-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe
Cipla Ltd
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077137-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Express Scripts
Medtronic
Moodys
Cerilliant
Argus Health
Queensland Health
Farmers Insurance
Accenture
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot